genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Search
About GEN
Contact GEN
Subscribe/Update Preferences
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Alzheimers
How DDT Contributes to Alzheimer’s Disease Risk
Metabolites
Artificial ‘Lily Pads’ for Solar Fuel Production Developed
Cell Signaling
Drug Candidate Absorbed via Lymphatic System Targets Cancer Cells in Mice
Virology
Researchers Uncover How Hepatitis E Escapes the Immune System
Blood Disorders
FDA Approves Bluebird Bio’s Lentiviral Gene Therapy to Treat Beta-Thalassemia
Insights
All
Trends for 2020
Trends for 2021
Bioprocessing
New Drying Methods May Help Vaccines Move to Continuous Manufacturing
Artificial Intelligence
Biopharma Will Learn to Embrace Machine Learning
Biomarkers
Exosomes Could Improve Inhaled Therapeutics
AAV (Adeno-associated virus)
Gene Therapy Developer Starts Early with Process Design
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
A-Lists
Seven Biopharma Trends to Watch in 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Home
Trends and Takeaways from J.P. Morgan 2021
GEN Edge Videos
Close to the Edge
Artificial Intelligence
From Knowledge, Drug Power: Andrew Hopkins Discusses AI-Based Development on “Close to the Edge”
Respiratory Drugs
Shehnaaz Suliman, MD, MPhil, Discusses Targeted Respiratory Therapies on “Close to the Edge”
Gene Therapy
Helen Sabzevari, PhD, of Precigen Connects Cancer and the Immune System on “Close to the Edge”
Molecular Biology
George Church, PhD, Recounts Decades of Research, 38 Companies on “Close to the Edge”
Cell Therapy
Eric Ostertag, MD, PhD, Recounts His Journey from Penn Grad to Poseida CEO on “Close to the Edge”
From IT to Biotech: Sujal Patel Discusses the Promise of the Proteome on “Close to the Edge”
Running Up That Hill: Nessan Bermingham on Close to the Edge
Hearing Aid: Decibel Therapeutics CEO Laurence Reid Talks to Close to the Edge
Beaming Up: CEO John Evans on the Future of Base Editing
Love is on the Air: The March to Cure Sickle Cell Disease
Going BIG: Daphne Zohar on “Close to the Edge”
Load more
Front Row
Front Row Series 2: AI in Drug Discovery and Development
Front Row Series 2: Andy Beck on AI
Front Row Series 2: Daphne Koller on AI
Part I: MassGeneral’s Rudy Tanzi, PhD, Shares New Genetic Findings on Alzheimer’s
Part II: LEXEO CEO R. Nolan Townsend Discusses Pioneering Alzheimer’s Gene Therapy
Part III: Hank Zetterberg, MD, PhD, Offers Insights into Alzheimer’s Biomarkers
GEN Edge Live
GEN Edge Live
“GEN Edge Live”: Analyzing the Latest Milestones in Genome Editing
GEN Edge Live
Trends and Takeaways from J.P. Morgan 2021
Read More
Scroll Up
